Terms: = Uterine cancer AND CCND1, BCL1, 595, ENSG00000110092, PRAD1, U21B31, D11S287E AND Prognosis
14 results:
1. Transcriptome analysis of an AKT inhibitor-resistant endometrial cancer cell line.
Onishi T; Takashima T; Shibahara K; Takagi S; Tanaka S; Mori M; Odashima H; Osawa Y; Hattori M
Pharmacol Rep; 2024 Apr; 76(2):379-389. PubMed ID: 38478219
[TBL] [Abstract] [Full Text] [Related]
2. ccnd1-Induced Autophagy Contributes to Lymph Node Metastasis in Endometrial cancer.
Su Y; Zhou H; Ma Z; Liu J; Li C
Horm Metab Res; 2023 Jun; 55(6):413-419. PubMed ID: 37019147
[TBL] [Abstract] [Full Text] [Related]
3. A federated approach to identify women with early-stage cervical cancer at low risk of lymph node metastases.
Wenzel HHB; Hardie AN; Moncada-Torres A; Høgdall CK; Bekkers RLM; Falconer H; Jensen PT; Nijman HW; van der Aa MA; Martin F; van Gestel AJ; Lemmens VEPP; Dahm-Kähler P; Alfonzo E; Persson J; Ekdahl L; Salehi S; Frøding LP; Markauskas A; Fuglsang K; Schnack TH
Eur J Cancer; 2023 May; 185():61-68. PubMed ID: 36965329
[TBL] [Abstract] [Full Text] [Related]
4. [Expression and significance of immune checkpoint B7-homolog 4 in endometrial cancer].
Zong LJ; Xiang Y; Yu SN; Lu ZH; Chen J; Huang WH
Zhonghua Fu Chan Ke Za Zhi; 2022 Dec; 57(12):921-931. PubMed ID: 36562226
[No Abstract] [Full Text] [Related]
5. Loss of LOXL2 Promotes uterine Hypertrophy and Tumor Progression by Enhancing H3K36ac-Dependent Gene Expression.
Lu X; Xin DE; Du JK; Zou QC; Wu Q; Zhang YS; Deng W; Yue J; Fan XS; Zeng Y; Cheng X; Li X; Hou Z; Mohan M; Zhao TC; Lu X; Chang Z; Xu L; Sun Y; Zu X; Zhang Y; Chinn YE
Cancer Res; 2022 Dec; 82(23):4400-4413. PubMed ID: 36197797
[TBL] [Abstract] [Full Text] [Related]
6. Prognostic value of the TCGA molecular classification in uterine carcinosarcoma.
Travaglino A; Raffone A; Raimondo D; Arciuolo D; Angelico G; Valente M; Scaglione G; D'alessandris N; Casadio P; Inzani F; Mollo A; Santoro A; Seracchioli R; Franco Zannoni G
Int J Gynaecol Obstet; 2022 Jul; 158(1):13-20. PubMed ID: 34536971
[TBL] [Abstract] [Full Text] [Related]
7. miR-142 Suppresses Endometrial cancer Proliferation In Vitro and In Vivo by Targeting Cyclin D1.
Su Y; Wang J; Ma Z; Gong W; Yu L
DNA Cell Biol; 2019 Feb; 38(2):144-150. PubMed ID: 30585737
[TBL] [Abstract] [Full Text] [Related]
8. Comparison of pelvic and para-aortic lymphadenectomy versus para-aortic lymphadenectomy alone for locally advanced FIGO stage IB2 to IIB cervical cancer using a propensity score matching analysis: Results from the FRANCOGYN study group.
Bendifallah S; de Foucher T; Ouldamer L; Bricou A; Lavoue V; Varinot J; Canlorbe G; Carcopino X; Raimond E; Huguet F; Graesslin O; Touboul C; Collinet P; Huchon C; Daraï E; Ballester M;
Eur J Surg Oncol; 2018 Dec; 44(12):1921-1928. PubMed ID: 30213717
[TBL] [Abstract] [Full Text] [Related]
9. Comparison of Automated and Conventional IHC Visual Scoring Analysis for MHC Class I and Tapasin Expression in Cervical Carcinoma.
Wanram S; Sombatwong J; Sakunpong A; Prasongdee P; Panomket P; Wongsena P; Limpaiboon T; Jearanaikoon P
J Med Assoc Thai; 2016 Jan; 99 Suppl 1():S67-75. PubMed ID: 26817241
[TBL] [Abstract] [Full Text] [Related]
10. [Association between ccnd1 G870A polymorphism and radiotherapy response in high-risk human papillomavirus-related cervical cancer].
Liang S; Zhang N; Huang R; Jiang J; Chen L; Lu Z; Li S
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2015 Nov; 40(11):1205-9. PubMed ID: 26643423
[TBL] [Abstract] [Full Text] [Related]
11. microRNA 31 functions as an endometrial cancer oncogene by suppressing Hippo tumor suppressor pathway.
Mitamura T; Watari H; Wang L; Kanno H; Kitagawa M; Hassan MK; Kimura T; Tanino M; Nishihara H; Tanaka S; Sakuragi N
Mol Cancer; 2014 Apr; 13():97. PubMed ID: 24779718
[TBL] [Abstract] [Full Text] [Related]
12. Fluorescence in situ hybridization markers for prediction of cervical lymph node metastases.
Wangsa D; Heselmeyer-Haddad K; Ried P; Eriksson E; Schäffer AA; Morrison LE; Luo J; Auer G; Munck-Wikland E; Ried T; Lundqvist EA
Am J Pathol; 2009 Dec; 175(6):2637-45. PubMed ID: 19893027
[TBL] [Abstract] [Full Text] [Related]
13. Intratumor chromosomal heterogeneity in advanced carcinomas of the uterine cervix.
Lyng H; Beigi M; Svendsrud DH; Brustugun OT; Stokke T; Kristensen GB; Sundfør K; Skjønsberg A; De Angelis PM
Int J Cancer; 2004 Sep; 111(3):358-66. PubMed ID: 15221962
[TBL] [Abstract] [Full Text] [Related]
14. Carcinoma of the endometrium. V. An analysis of prognosticators in patients with favorable subtypes and Stage I disease.
Christopherson WM; Connelly PJ; Alberhasky RC
Cancer; 1983 May; 51(9):1705-9. PubMed ID: 6831367
[TBL] [Abstract] [Full Text] [Related]
